We are live on ! Find out more
IMPV

Imperva, Inc.
IMPV

Delisted

IMPV was delisted on the 9th of January, 2019.

120 hedge funds and large institutions have $543M invested in Imperva, Inc. in 2014 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 44 increasing their positions, 30 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

51% more call options, than puts

Call options by funds: $15.7M | Put options by funds: $10.4M

47% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 30

8% less funds holding

Funds holding: 130120 (-10)

22% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 46

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

54% less capital invested

Capital invested by funds: $1.17B → $543M (-$627M)

Holders
120
Holders Change
-10
Holders Change %
-7.69%
% of All Funds
3.45%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
36
Increased
44
Reduced
30
Closed
46
Calls
$15.7M
Puts
$10.4M
Net Calls
+$5.3M
Net Calls Change
+$5.84M
Name Holding Trade Value Shares
Change
Change in
Stake
Swiss National Bank
76
Swiss National Bank
Switzerland
$542K +$69.7K +2,700 +15%
ZL
77
Zeke LP
Pennsylvania
$524K +$64.6K +2,500 +14%
BPGAM
78
BTG Pactual Global Asset Management
Bermuda
$521K +$240K +9,310 +88%
Goldman Sachs
79
Goldman Sachs
New York
$504K +$205K +7,927 +70%
RhumbLine Advisers
80
RhumbLine Advisers
Massachusetts
$470K +$14.4K +559 +3%
AL
81
Aspiriant LLC
California
$458K
PSC
82
Piper Sandler & Co
Minnesota
$458K +$452K +17,500 New
Jennison Associates
83
Jennison Associates
New York
$439K -$281K -10,874 -39%
MLICM
84
Metropolitan Life Insurance Company (MetLife)
New York
$427K
TC
85
TFS Capital
Pennsylvania
$420K -$846K -32,765 -67%
Manulife (Manufacturers Life Insurance)
86
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$382K -$22.2K -858 -6%
ZIM
87
Zacks Investment Management
Illinois
$382K +$377K +14,587 New
AIG
88
American International Group
New York
$379K +$18.9K +732 +5%
D.E. Shaw & Co
89
D.E. Shaw & Co
New York
$378K +$224K +8,675 +150%
PG
90
PEAK6 Group
Illinois
$355K +$342K +13,246 +4,415%
PAM
91
Paradigm Asset Management
New York
$314K +$310K +12,000 New
ProShare Advisors
92
ProShare Advisors
Maryland
$282K -$249K -9,660 -47%
Capital Fund Management (CFM)
93
Capital Fund Management (CFM)
France
$280K +$276K +10,700 New
BA
94
BlackRock Advisors
Delaware
$247K -$26K -1,006 -10%
Bank of America
95
Bank of America
North Carolina
$246K +$167K +6,450 +220%
VanEck Associates
96
VanEck Associates
New York
$234K +$56.6K +2,191 +33%
GT
97
Glenmede Trust
Pennsylvania
$232K +$14.3K +554 +7%
WCM
98
Washington Capital Management
Washington
$219K +$75.7K +2,932 +54%
Parallax Volatility Advisers
99
Parallax Volatility Advisers
California
$140K +$138K +5,347 New
PAM
100
Panagora Asset Management
Massachusetts
$129K

IMPV Hedge Fund Activity: Q2 2014 in Review

120 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Imperva, Inc. (IMPV) for Q2 2014, worth a combined $543M — down 54% from $1.17B a quarter earlier.

Sellers outnumbered buyers: 46 funds closed out of IMPV and 36 opened new positions — a net loss of 10 holders — while 30 trimmed existing stakes and 44 added.

The largest buyer was Fidelity Investments, adding an estimated $73.9M. The largest seller was Next Century Growth Investors, exiting entirely with an estimated $42.7M sold.

  • 120 institutional investors held Imperva, Inc. (IMPV) as of Q2 2014, down from 130 in Q1 2014.
  • Funds reported $543M of Imperva, Inc. stock for Q2 2014, down 54% quarter-over-quarter.
  • 36 funds opened new Imperva, Inc. positions in Q2 2014 and 46 closed out, a net change of -10 holders.
  • The largest Imperva, Inc. buyer in Q2 2014 was Fidelity Investments, an estimated $73.9M added.
  • The largest Imperva, Inc. seller in Q2 2014 was Next Century Growth Investors, an estimated $42.7M sold.

Based on aggregated 13F filings for Q2 2014.